Cardinal Health's GMPD: A Deep Dive into US Medical Distribution Strategy for 2025

This episode provides a detailed analysis of Cardinal Health's Global Medical Products & Distribution (GMPD) segment, a dominant force in the U.S. medical supply market. We explore its business model, recent financial performance through FY2024 and FY2025, and its strategic importance for healthcare providers. The discussion covers how its private-label brands and national logistics network make it a top-tier distribution partner for cost-conscious and quality-focused sourcing strategies in 2025. Key Questions: - What makes Cardinal Health's GMPD segment a leader in U.S. medical distribution? - How did Cardinal Health achieve steady growth through fiscal years 2024 and 2025? - Why is transparency in financial reporting a key advantage for their med-surg business? - What role do private-label brands play in a modern healthcare sourcing strategy? - How does Cardinal Health fit into a dual-source strategy against its top competitors? - What are the key criteria for selecting a "Big-Three" distributor in 2025? - How can integrated analytics and a national footprint benefit healthcare providers? Navigating the U.S. market requires a robust distribution strategy, as exemplified by leaders like Cardinal Health. For MedTech and IVD companies looking to expand globally, a strong regulatory partner is just as critical. Pure Global offers end-to-end consulting solutions, from developing efficient regulatory pathways to acting as your local representative in over 30 markets. Our advanced AI tools streamline the creation of technical dossiers and provide crucial market insights, ensuring your products reach new territories faster. Let us help you build a seamless global market access strategy. Visit us at https://pureglobal.com, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.